ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Cytotoxicity of Myrtenal on Different Human Cancer Cell Lines

Engin Korkmaz,Suat Tekin.



Abstract
Download PDF Cited by 1 ArticlesPost

Aim: Myrtenal (Myrt), a monoterpene found in essential oils of various plant species, such as Citrus aurantium, Citrus limon, Mentha japonica and Zingiber officinale roscoe. Preclinical studies have reported that Myrt induces apoptosis in various cancer models. This study aimed to investigate the effects of Myrt on cell viability in human prostate (LNCaP), colon (Caco-2), breast (MCF-7) and ovarian (A2780) cancer cell lines.
Materials and Methods: A2780, LNCaP, MCF-7 and Caco-2 cell lines were used in this study. All cell lines were treated with 1, 5, 25, 50 and 100 μM concentrations of Myrt for 24 hours. Changes in cell viability were determined by the MTT assay. The inhibitory concentration 50 (IC50) and logIC50 values of Myrt in cell lines was calculated based on the cytotoxicity results.
Results: Myrt concentrations applied to Caco-2, A2780, MCF-7 and LNCaP cancer cell lines for 24 hours significantly decreased cell viability (%) (p

Key words: myrtenal, cancer, cytotoxicity







Bibliomed Article Statistics

34
22
17
37
23
15
21
18
13
16
23
22
R
E
A
D
S

7

12

13

23

13

11

11

8

17

14

10

18
D
O
W
N
L
O
A
D
S
030405060708091011120102
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.